HCPCS drug code · CMS crosswalk
Fondaparinux Sodium J-Code / HCPCS Code
In short
Fondaparinux Sodium is billed under HCPCS J1652 — Injection, fondaparinux sodium, 0.5 mg. One billing unit is 0.5 mg. CMS's crosswalk lists 23 Fondaparinux Sodium NDCs under this code.
Reference
- J1652
- Injection, fondaparinux sodium, 0.5 mgBilling unit: 0.5 mg
- Labelers
- Dr. Reddy's Laboratories Inc.; Eugia US LLC; Mylan Institutional LLC; Sandoz Inc.; Zydus Pharmaceuticals (USA) Inc.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Fondaparinux Sodium units and claim line
Enter the dose given to get the J1652 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Fondaparinux Sodium NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00781-3443-95 | J1652 | Sandoz Inc. | 10 × 0.5 | 50 |
| 00781-3454-95 | J1652 | Sandoz Inc. | 10 × 0.4 | 100 |
| 00781-3465-95 | J1652 | Sandoz Inc. | 10 × 0.6 | 150 |
| 00781-3476-95 | J1652 | Sandoz Inc. | 10 × 0.8 | 200 |
| 55111-0678-02 | J1652 | Dr. Reddy's Laboratories Inc. | 2 × 0.5 | 10 |
| 55111-0678-10 | J1652 | Dr. Reddy's Laboratories Inc. | 10 × 0.5 | 50 |
| 55111-0679-02 | J1652 | Dr. Reddy's Laboratories Inc. | 2 × 0.4 | 20 |
| 55111-0679-10 | J1652 | Dr. Reddy's Laboratories Inc. | 10 × 0.4 | 100 |
| 55111-0680-02 | J1652 | Dr. Reddy's Laboratories Inc. | 2 × 0.6 | 30 |
| 55111-0680-10 | J1652 | Dr. Reddy's Laboratories Inc. | 10 × 0.6 | 150 |
| 55111-0681-02 | J1652 | Dr. Reddy's Laboratories Inc. | 2 × 0.8 | 40 |
| 55111-0681-10 | J1652 | Dr. Reddy's Laboratories Inc. | 10 × 0.8 | 200 |
| 55150-0230-10 | J1652 | Eugia US LLC | 10 × 0.5 | 50 |
| 55150-0231-10 | J1652 | Eugia US LLC | 10 × 0.4 | 100 |
| 55150-0232-10 | J1652 | Eugia US LLC | 10 × 0.6 | 150 |
| 55150-0233-10 | J1652 | Eugia US LLC | 10 × 0.8 | 200 |
| 67457-0582-10 | J1652 | Mylan Institutional LLC | 10 × 0.5 | 50 |
| 67457-0583-04 | J1652 | Mylan Institutional LLC | 10 × 0.4 | 100 |
| 67457-0584-06 | J1652 | Mylan Institutional LLC | 10 × 0.6 | 150 |
| 67457-0585-08 | J1652 | Mylan Institutional LLC | 10 × 0.8 | 200 |
| 70710-1514-06 | J1652 | Zydus Pharmaceuticals (USA) Inc. | 10 × 0.5 | 50 |
| 70710-1514-09 | J1652 | Zydus Pharmaceuticals (USA) Inc. | 2 × 0.5 | 10 |
| 70710-1515-06 | J1652 | Zydus Pharmaceuticals (USA) Inc. | 10 × 0.4 | 100 |
Fondaparinux Sodium: common questions
- What is the J-code for Fondaparinux Sodium?
- Fondaparinux Sodium is billed under HCPCS J1652 — Injection, fondaparinux sodium, 0.5 mg. One billing unit is 0.5 mg. CMS's crosswalk lists 23 Fondaparinux Sodium NDCs under this code.
- How many J1652 billing units are in a package of Fondaparinux Sodium?
- CMS lists 10 to 200 billing units per package, depending on the NDC, where one unit is 0.5 mg. Units to report are based on the dose given, not the package.
- Is J1652 a CPT code?
- No. J1652 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.